2012
DOI: 10.3109/10641963.2012.666600
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Cilnidipine on Serum Uric Acid Level and Urinary Nitrogen Monoxide Excretion in Patients with Hypertension

Abstract: The effects of cilnidipine on the serum uric acid level and urinary NO excretion in hypertensive patients were investigated. Blood and urine samples of 16 hypertensive outpatients were collected before and 2 months after cilnidipine therapy (10 mg). The serum uric acid level decreased significantly after cilnidipine treatment, while the uric acid-creatinine clearance ratio was unaffected. The cilnidipine medication produced a significant increase in urinary NO excretion, although amlodipine did not change it s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 12 publications
0
3
0
Order By: Relevance
“…[46][47][48] In one human study, cilnidipine induced significant reduction in blood pressure and sU level from a mean AE SD at baseline of 5.6AE0.3 mg/dL to 5.1AE0.2 mg/dL (P<.01). 49 Perhaps consistent with a urate-lowering effect, studies also indicate that CCBs may decrease the risk of gout. 50,51 Compared with no use of CCBs, CCB use was found to be associated with a 0.87 (95% CI, 0.82 to 0.93) relative risk for incident gout in patients with hypertension after adjusting for age, sex, and use of other antihypertensive drugs.…”
Section: Lowering and Raising Serum Urate Levelsmentioning
confidence: 87%
“…[46][47][48] In one human study, cilnidipine induced significant reduction in blood pressure and sU level from a mean AE SD at baseline of 5.6AE0.3 mg/dL to 5.1AE0.2 mg/dL (P<.01). 49 Perhaps consistent with a urate-lowering effect, studies also indicate that CCBs may decrease the risk of gout. 50,51 Compared with no use of CCBs, CCB use was found to be associated with a 0.87 (95% CI, 0.82 to 0.93) relative risk for incident gout in patients with hypertension after adjusting for age, sex, and use of other antihypertensive drugs.…”
Section: Lowering and Raising Serum Urate Levelsmentioning
confidence: 87%
“…2 ). Studies by Hamada et al reported significant decrease in the SUA level and increased urinary nitrogen monoxide synthesis in hypertensive patients after treatment with cilnidipine [ 20 ]. Improvement of uric acid metabolism in hypertensive patients with CKD receiving cilnidipine has been observed in study by Uchida et al [ 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…Neither serum uric acid nor clearance and fractional excretion of uric acid changed significantly during 10-day treatment with nifedipine [43], while recent evidence suggested nifedipine has been found to reduce serum uric acid levels compared with a placebo in the A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION) trial [44]. Furthermore, it has been suggested that amlodipine and cilnidipine might reduce serum uric acid level [45,46]. Captopril and enalapril increased uric acid excretion, and captopril significantly reduced serum uric acid in hypertensive patients with hyperuricemia [47], while it has been reported that ACEinhibitors have not been associated with lower serum uric levels [48,49].…”
Section: Antihypertensives (Sartans Calcium Channel Blockers)mentioning
confidence: 99%